By Professor David Simon Ziegler

Journal articles

Das A; Sudhaman S; Morgenstern D; Coblentz A; Chung J; Stone SC; Alsafwani N; Liu ZA; Karsaneh OAA; Soleimani S; Ladany H; Chen D; Zatzman M; Cabric V; Nobre L; Bianchi V; Edwards M; Sambira Nahum LC; Ercan AB; Nabbi A; Constantini S; Dvir R; Yalon-Oren M; Campino GA; Caspi S; Larouche V; Reddy A; Osborn M; Mason G; Lindhorst S; Bronsema A; Magimairajan V; Opocher E; De Mola RL; Sabel M; Frojd C; Sumerauer D; Samuel D; Cole K; Chiaravalli S; Massimino M; Tomboc P; Ziegler DS; George B; Van Damme A; Hijiya N; Gass D; McGee RB; Mordechai O; Bowers DC; Laetsch TW; Lossos A; Blumenthal DT; Sarosiek T; Yen LY; Knipstein J; Bendel A; Hoffman LM; Luna-Fineman S; Zimmermann S; Scheers I; Nichols KE; Zapotocky M; Hansford JR; Maris JM; Dirks P; Taylor MD; Kulkarni AV; Shroff M; Tsang DS; Villani A; Xu W; Aronson M; Durno C; Shlien A; Malkin D; Getz G; Maruvka YE; Ohashi PS; Hawkins C; Pugh TJ; Bouffet E; Tabori U, 2022, 'Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency', Nature Medicine, 28, pp. 125 - 135, http://dx.doi.org/10.1038/s41591-021-01581-6

Fischer M; Moreno L; Ziegler DS; Marshall LV; Zwaan CM; Irwin MS; Casanova M; Sabado C; Wulff B; Stegert M; Wang L; Hurtado FK; Branle F; Geoerger B; Schulte JH, 2021, 'Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study', The Lancet Oncology, 22, pp. 1764 - 1776, http://dx.doi.org/10.1016/S1470-2045(21)00536-2

Manoharan N; Ajuyah P; Senapati A; Wong M; Mullins A; Rodriguez M; Doyle H; McCowage G; Lau LMS; Ekert PG; Ziegler DS, 2021, 'Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis', Acta Neuropathologica Communications, 9, http://dx.doi.org/10.1186/s40478-021-01248-w

Khan A; Gamble LD; Upton DH; Ung C; Yu DMT; Ehteda A; Pandher R; Mayoh C; Hébert S; Jabado N; Kleinman CL; Burns MR; Norris MD; Haber M; Tsoli M; Ziegler DS, 2021, 'Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas', Nature Communications, 12, pp. 971, http://dx.doi.org/10.1038/s41467-021-20896-z

Nagabushan S; Lau LMS; Barahona P; Wong M; Sherstyuk A; Marshall GM; Tyrrell V; Wegner EA; Ekert PG; Cowley MJ; Mayoh C; Trahair TN; Crowe P; Anazodo A; Ziegler DS, 2021, 'Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor', npj Precision Oncology, 5, http://dx.doi.org/10.1038/s41698-021-00145-8

Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; Van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD, 2021, 'Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes', JAMA Oncology, 7, pp. 1806 - 1814, http://dx.doi.org/10.1001/jamaoncol.2021.4536

Hayden E; Holliday H; Lehmann R; Khan A; Tsoli M; Rayner BS; Ziegler DS, 2021, 'Therapeutic targets in diffuse midline gliomas—an emerging landscape', Cancers, 13, http://dx.doi.org/10.3390/cancers13246251

Doz F; van Tilburg CM; Geoerger B; Nysom K; Øra I; Boni V; Chisholm J; Chung HC; DuBois SG; Melcón SG; Gerber NU; Goto H; Grilley-Olsen JE; Hansford JR; Hong DS; Italiano A; Kang HJ; Capra M; Schulte JH; Stefanowicz J; Tahara M; Ziegler DS; Gavrilovic IT; Norenberg R; Dima L; De La Cuesta E; Laetsch TW; Drilon A; Perreault S, 2021, 'CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS', Neuro-Oncology, 23, pp. vi73 - vi74, http://dx.doi.org/10.1093/neuonc/noab196.283

Lazow M; Nievelstein M; Lane A; Bandopadhayay P; DeWire-Schottmiller M; Fouladi M; Glod J; Greiner R; Hoffman L; Hummel T; Kilburn L; Leary S; Minturn J; Packer R; Ziegler DS; Chaney B; Black K; de Blank P; Leach J, 2021, 'NIMG-11. VOLUMETRIC ENDPOINTS IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): COMPARISON TO CROSS-SECTIONAL MEASURES AND CORRELATION WITH OUTCOMES', Neuro-Oncology, 23, pp. vi129 - vi130, http://dx.doi.org/10.1093/neuonc/noab196.511

Burke MJ; Ziegler DS; Bautista F; Attarbaschi A; Gore L; Locatelli F; O'Brien MM; Pauly M; Obreja M; Morris CL; Baruchel A, 2021, 'Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)', Blood, 138, pp. 1235 - 1235, http://dx.doi.org/10.1182/blood-2021-147588

Ziegler DS; Huynh V; Burke MJ; Gore L; Locatelli F; O'Brien MM; Kim C; Obreja M; Morris CL; Baruchel A, 2021, 'Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)', Blood, 138, pp. 4403 - 4403, http://dx.doi.org/10.1182/blood-2021-153865

Khan S; Solano-Paez P; Suwal T; Lu M; Al-Karmi S; Ho B; Mumal I; Shago M; Hoffman LM; Dodgshun A; Nobusawa S; Tabori U; Bartels U; Ziegler DS; Hansford JR; Ramaswamy V; Hawkins C; Dufour C; André N; Bouffet E; Huang A; Gonzalez CV A; Stephens D; Leary S; Marrano P; Fonseca A; Thacker N; Li BK; Lindsay HB; Lassaletta A; Bendel AE; Moertel C; Morales La Madrid A; Santa-Maria V; Lavarino C; Rivas E; Perreault S; Ellezam B; Weil AG; Jabado N; Oviedo A; Yalon-Oren M; Amariglio L; Toledano H; Dvir R; Loukides J; Van Meter TE; Nakamura H; Wong TT; Wu KS; Cheng CJ; Ra YS; La Spina M; Massimi L; Buccoliero AM; Reddy A; Li R; Gillespie GY; Adamek D; Fangusaro J; Scharnhorst D; Torkildson J; Johnston D; Michaud J; LafayCousin L; Chan J; Van Landeghem F; Wilson B; Camelo-Piragua S; Kabbara N; Boutarbouch M; Hanson D; Jacobsen C; Wright K; Vibhakar R; Levy JM; Wang Y; Catchpoole D; Gerber N; Grotzer MA; Shen V; Plant A; Dunham C; Joao Gil da Costa M; Ramanujachar R; Raabe E; Rubens J; Phillips J; Gupta N; Demir HA; Dahl C; Jorgensen M; Hwang EI; Packer RJ; Smith A; Tan E; Low S; Lu JQ; Ng HK; Kresak JL, 2021, 'Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study', The Lancet Child and Adolescent Health, 5, pp. 800 - 813, http://dx.doi.org/10.1016/S2352-4642(21)00245-5

Meyran D; Terry RL; Zhu JJ; Haber M; Ziegler DS; Ekert PG; Trapani JA; Darcy PK; Neeson PJ, 2021, 'Early-phenotype CAR-T cells for the treatment of pediatric cancers', Annals of Oncology, 32, pp. 1366 - 1380, http://dx.doi.org/10.1016/j.annonc.2021.07.018

Terry RL; Meyran D; Fleuren EDG; Mayoh C; Zhu J; Omer N; Ziegler DS; Haber M; Darcy PK; Trapani JA; Neeson PJ; Ekert PG, 2021, 'Chimeric antigen receptor t cell therapy and the immunosuppressive tumor microenvironment in pediatric sarcoma', Cancers, 13, pp. 4704, http://dx.doi.org/10.3390/cancers13184704

Durno C; Ercan AB; Bianchi V; Edwards M; Aronson M; Galati M; Atenafu EG; Abebe-Campino G; Al-Battashi A; Alharbi M; Azad VF; Baris HN; Basel D; Bedgood R; Bendel A; Ben-Shachar S; Blumenthal DT; Blundell M; Bornhorst M; Bronsema A; Cairney E; Rhode S; Caspi S; Chamdin A; Chiaravalli S; Constantini S; Crooks B; Das A; Dvir R; Farah R; Foulkes WD; Frenkel Z; Gallinger B; Gardner S; Gass D; Ghalibafian M; Gilpin C; Goldberg Y; Goudie C; Hamid SA; Hampel H; Hansford JR; Harlos C; Hijiya N; Hsu S; Kamihara J; Kebudi R; Knipstein J; Koschmann C; Kratz C; Larouche V; Lassaletta A; Lindhorst S; Ling SC; Link MP; De Mola RL; Luiten R; Lurye M; Maciaszek JL; MagimairajanIssai V; Maher OM; Massimino M; McGee RB; Mushtaq N; Mason G; Newmark M; Nicholas G; Nichols KE; Nicolaides T; Opocher E; Osborn M; Oshrine B; Pearlman R; Pettee D; Rapp J; Rashid M; Reddy A; Reichman L; Remke M; Robbins G; Roy S; Sabel M; Samuel D; Scheers I; Schneider KW; Sen S; Stearns D; Sumerauer D; Swallow C; Taylor L; Thomas G; Toledano H; Tomboc P; Van Damme A; Winer I; Yalon M; Yen LY; Zapotocky M; Zelcer S; Ziegler DS, 2021, 'Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance', Journal of Clinical Oncology, 39, pp. 2779 - 2790, http://dx.doi.org/10.1200/JCO.20.02636

Michniewicz F; Saletta F; Rouaen JRC; Hewavisenti RV; Mercatelli D; Cirillo G; Giorgi FM; Trahair T; Ziegler D; Vittorio O, 2021, 'Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics', ChemMedChem, 16, pp. 2315 - 2329, http://dx.doi.org/10.1002/cmdc.202100172

Xiao L; Somers K; Murray J; Pandher R; Karsa M; Ronca E; Bongers A; Terry R; Ehteda A; Gamble LD; Issaeva N; Leonova KI; O’Connor A; Mayoh C; Venkat P; Quek H; Brand J; Kusuma FK; Pettitt JA; Mosmann E; Kearns A; Eden G; Alfred S; Allan S; Zhai L; Kamili A; Gifford AJ; Carter DR; Henderson MJ; Fletcher JI; Marshall G; Johnstone RW; Cesare AJ; Ziegler DS; Gudkov AV; Gurova KV; Norris MD; Haber M, 2021, 'Dual targeting of chromatin stability by the curaxin CBL0137 and histone deacetylase inhibitor panobinostat shows significant preclinical efficacy in neuroblastoma', Clinical Cancer Research, 27, pp. 4338 - 4352, http://dx.doi.org/10.1158/1078-0432.CCR-20-2357

Hau P; Frappaz D; Hovey E; McCabe MG; Pajtler KW; Wiestler B; Seidel C; Combs SE; Dirven L; Klein M; Anazodo A; Hattingen E; Hofer S; Pfister SM; Zimmer C; Kortmann RD; Sunyach MP; Tanguy R; Effeney R; von Deimling A; Sahm F; Rutkowski S; Berghoff AS; Franceschi E; Pineda E; Beier D; Peeters E; Gorlia T; Vanlancker M; Bromberg JEC; Gautier J; Ziegler DS; Preusser M; Wick W; Weller M, 2021, 'Development of randomized trials in adults with medulloblastoma—the example of eortc 1634-btg/noa-23', Cancers, 13, http://dx.doi.org/10.3390/cancers13143451

Perreault S; Doz F; Geoerger B; Nysom K; Øra I; Boni V; Chisholm J; DuBois SG; Gerber NU; Goto H; Grilley-Olson JE; Hansford JR; Kang HJ; Capra M; Schulte JH; Stefanowicz J; Tahara M; Ziegler DS; Norenberg R; Dima L; De La Cuesta E; Laetsch TW; van Tilburg CM, 2021, 'RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS', Neuro-Oncology, 23, pp. i42 - i42, http://dx.doi.org/10.1093/neuonc/noab090.168

Kilburn LB; Jabado N; Franson A; Chi SN; Fisher MJ; Hargrave DR; Hansford JR; Ziegler DS; Landi D; Kang HJ; Gerber NU; Yalon-Oren M; Cornelio I; Blackman SC; Cox MC; Witt O; Prados M; Mueller S, 2021, 'FIREFLY-1: A phase 2 study of the pan-RAF inhibitor DAY101 in pediatric patients with low-grade glioma.', Journal of Clinical Oncology, 39, pp. TPS10056 - TPS10056, http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps10056

Morgenstern DA; Mascarenhas L; Campbell M; Ziegler DS; Nysom K; Casanova M; Pappo AS; Albert CM; Xia M; Barker SS; Wright J; Laetsch TW, 2021, 'Oral selpercatinib in pediatric patients (pts) with advanced RET-altered solid or primary CNS tumors: Preliminary results from the phase 1/2 LIBRETTO-121 trial.', Journal of Clinical Oncology, 39, pp. 10009 - 10009, http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10009

Chung J; Maruvka YE; Sudhaman S; Kelly J; Haradhvala NJ; Bianchi V; Edwards M; Forster VJ; Nunes NM; Galati MA; Komosa M; Deshmukh S; Cabric V; Davidson S; Zatzman M; Light N; Hayes R; Brunga L; Anderson ND; Ho B; Hodel KP; Siddaway R; Morrissy AS; Bowers DC; Larouche V; Bronsema A; Osborn M; Cole KA; Opocher E; Mason G; Thomas GA; George B; Ziegler DS; Lindhorst S; Vanan M; Yalon-Oren M; Reddy AT; Massimino M; Tomboc P; Van Damme A; Lossos A; Durno C; Aronson M; Morgenstern DA; Bouffet E; Huang A; Taylor MD; Villani A; Malkin D; Hawkins CE; Pursell ZF; Shlien A; Kunkel TA; Getz G; Tabori U, 2021, 'DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells', Cancer Discovery, 11, pp. 1176 - 1191, http://dx.doi.org/10.1158/2159-8290.CD-20-0790

Hamasaki T; Harris PG; Bureau NJ; Gaudreault N; Ziegler D; Choinière M, 2021, 'Efficacy of Surgical Interventions for Trapeziometacarpal (Thumb Base) Osteoarthritis: A Systematic Review', Journal of Hand Surgery Global Online, 3, pp. 139 - 148, http://dx.doi.org/10.1016/j.jhsg.2021.02.003

Ryan AL; Burns C; Gupta AK; Samarasekera R; Ziegler DS; Kirby ML; Alvaro F; Downie P; Laughton SJ; Cross S; Hassall T; McCowage GB; Hansford JR; Kotecha RS; Gottardo NG, 2021, 'Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children’s Oncology Group (ANZCHOG) Study', Frontiers in Oncology, 11, http://dx.doi.org/10.3389/fonc.2021.660172

Ehteda A; Simon S; Franshaw L; Giorgi FM; Liu J; Joshi S; Rouaen JRC; Pang CNI; Pandher R; Mayoh C; Tang Y; Khan A; Ung C; Tolhurst O; Kankean A; Hayden E; Lehmann R; Shen S; Gopalakrishnan A; Trebilcock P; Gurova K; Gudkov AV; Norris MD; Haber M; Vittorio O; Tsoli M; Ziegler DS, 2021, 'Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG', Cell Reports, 35, pp. 108994, http://dx.doi.org/10.1016/j.celrep.2021.108994

Gamble LD; Purgato S; Henderson MJ; Di Giacomo S; Russell AJ; Pigini P; Murray J; Valli E; Milazzo G; Giorgi FM; Cowley M; Ashton LJ; Bhalshankar J; Schleiermacher G; Rihani A; Van Maerken T; Vandesompele J; Speleman F; Versteeg R; Koster J; Eggert A; Noguera R; Stallings RL; Tonini GP; Fong K; Vaksman Z; Diskin SJ; Maris JM; London WB; Marshall GM; Ziegler DS; Hogarty MD; Perini G; Norris MD; Haber M, 2021, 'A g316a polymorphism in the ornithine decarboxylase gene promoter modulates mycn‐driven childhood neuroblastoma', Cancers, 13, pp. 1807, http://dx.doi.org/10.3390/cancers13081807

Janjua TI; Rewatkar P; Ahmed-Cox A; Saeed I; Mansfeld FM; Kulshreshtha R; Kumeria T; Ziegler DS; Kavallaris M; Mazzieri R; Popat A, 2021, 'Frontiers in the treatment of glioblastoma: Past, present and emerging', Advanced Drug Delivery Reviews, 171, pp. 108 - 138, http://dx.doi.org/10.1016/j.addr.2021.01.012

Ung C; Tsoli M; Liu J; Cassano D; Pocoví-Martínez S; Upton DH; Ehteda A; Mansfeld FM; Failes TW; Farfalla A; Katsinas C; Kavallaris M; Arndt GM; Vittorio O; Cirillo G; Voliani V; Ziegler DS, 2021, 'Doxorubicin-loaded gold nanoarchitectures as a therapeutic strategy against diffuse intrinsic pontine glioma', Cancers, 13, pp. 1 - 20, http://dx.doi.org/10.3390/cancers13061278

Himes RW; Chiou EH; Queliza K; Shouval DS; Somech R; Agarwal S; Jajoo K; Ziegler DS; Kratz CP; Huang J; Lucas TL; Myers KC; Nelson AS; DiNardo CD; Alter BP; Giri N; Khincha PP; McReynolds LJ; Dufour C; Pierri F; Goldman FD; Sherif Y; Savage SA; Miloh T; Bertuch AA, 2021, 'Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders', Journal of Pediatrics, 230, pp. 55 - 61.e4, http://dx.doi.org/10.1016/j.jpeds.2020.09.038

Dufort G; Chen BY; Jacquin G; Keezer M; Labrie M; Rioux B; Stapf C; Ziegler D; Poppe AY, 2021, 'Acute carotid stenting in patients undergoing thrombectomy: A systematic review and meta-analysis', Journal of NeuroInterventional Surgery, 13, pp. 141 - 145, http://dx.doi.org/10.1136/neurintsurg-2020-015817

Haeusler GM; De Abreu Lourenco R; Clark H; Thursky KA; Slavin MA; Babl FE; Mechinaud F; Alvaro F; Clark J; Padhye B; Phillips M; Super L; Tapp H; Walwyn T; Ziegler D; Phillips R; Worth LJ, 2021, 'Diagnostic Yield of Initial and Consecutive Blood Cultures in Children with Cancer and Febrile Neutropenia', Journal of the Pediatric Infectious Diseases Society, 10, pp. 125 - 130, http://dx.doi.org/10.1093/jpids/piaa029

Robertson EG; Wakefield CE; Tsoli M; Kellie SJ; Alvaro F; Gifford AJ; Weber MA; Rodriguez M; Kirby M; Ziegler DS, 2021, 'Parents' experiences of postmortem tumor donation for high-grade gliomas: Benefits and suggested improvements', Neuro-Oncology Advances, 3, pp. vdab087, http://dx.doi.org/10.1093/noajnl/vdab087

Xie J; Kumar A; Dolman MEM; Mayoh C; Khuong-Quang DA; Cadiz R; Wong-Erasmus M; Mould EVA; Grebert-Wade D; Barahona P; Kamili A; Tsoli M; Failes TW; Chow SO; Bhatia K; Marshall GM; Ziegler DS; Haber M; Lock RB; Tyrrell V; Lau L; Athanasatos P; Gifford AJ; Arndt G, 2021, 'The important role of routine cytopathology in pediatric precision oncology', Cancer Cytopathology, 129, pp. 805 - 818, http://dx.doi.org/10.1002/cncy.22448

Chen CCL; Deshmukh S; Jessa S; Hadjadj D; Lisi V; Andrade AF; Faury D; Jawhar W; Dali R; Suzuki H; Pathania M; A D; Dubois F; Woodward E; Hébert S; Coutelier M; Karamchandani J; Albrecht S; Brandner S; De Jay N; Gayden T; Bajic A; Harutyunyan AS; Marchione DM; Mikael LG; Juretic N; Zeinieh M; Russo C; Maestro N; Bassenden AV; Hauser P; Virga J; Bognar L; Klekner A; Zapotocky M; Vicha A; Krskova L; Vanova K; Zamecnik J; Sumerauer D; Ekert PG; Ziegler DS; Ellezam B; Filbin MG; Blanchette M; Hansford JR; Khuong-Quang DA; Berghuis AM; Weil AG; Garcia BA; Garzia L; Mack SC; Beroukhim R; Ligon KL; Taylor MD; Bandopadhayay P; Kramm C; Pfister SM; Korshunov A; Sturm D; Jones DTW; Salomoni P; Kleinman CL; Jabado N, 2020, 'Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis', Cell, 183, pp. 1617 - 1633.e22, http://dx.doi.org/10.1016/j.cell.2020.11.012

Wood P; Desai J; Waldeck K; Cain J; Gottardo N; Strong R; Kinross K; Carr M; Jones J; Wong L; Ziegler D; Hansford J; Michael M; Ashley D, 2020, 'ATRT-08. A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS', Neuro-Oncology, 22, pp. iii277 - iii277, http://dx.doi.org/10.1093/neuonc/noaa222.008

Lazow MA; Fuller C; Lane A; DeWire-Schottmiller MD; Bandopadhayay P; Bartels U; Bouffet E; Cheng S; Cohen KJ; Cooney TM; Coven SL; Dholaria H; Diez B; Dorris K; El-Ayadi M; El-Sheikh A; Fisher PG; Lombardi MG; Greiner RJ; Goldman S; Gottardo N; Gururangan S; Hansford JR; Hassall T; Hawkins C; Kilburn L; Koschmann CJ; Leary SE; Ma J; Minturn JE; Monje-Deisseroth M; Packer RJ; Samson Y; Sandler ES; Sevlever G; Tinkle C; Tsui K; Wagner LM; Zaghloul M; Ziegler DS; Chaney B; Black K; Asher A; Drissi R; Fouladi M; Jones BV; Leach JL, 2020, 'DIPG-46. NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW', Neuro-Oncology, 22, pp. iii295 - iii296, http://dx.doi.org/10.1093/neuonc/noaa222.092

Michniewicz F; Saletta F; Rouen J; Ziegler D; Vittorio O, 2020, 'DIPG-83. USING COPPER CHELATING AGENTS TO TARGET RECEPTOR TYROSINE KINASE SIGNALLING IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', Neuro-Oncology, 22, pp. iii303 - iii303, http://dx.doi.org/10.1093/neuonc/noaa222.124

Goto H; Geoerger B; DuBois SG; Grilley-Olson JE; van Tilburg CM; Schulte J; Kang HJ; Tahara M; Boni V; Perreault S; Capra M; Reeves JA; Brega N; Childs BH; Laetsch TW; Ziegler DS; Doz F, 2020, 'EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS', Neuro-Oncology, 22, pp. iii305 - iii305, http://dx.doi.org/10.1093/neuonc/noaa222.132

Hanson D; Andre N; Chi S; Filbin M; Fisher M; Hoffman L; Khatib Z; Kool M; Narendran A; Pizer B; Slavc I; Vogel T; Ziegler D; Kieran M, 2020, 'ETMR-08. INTERNATIONAL CONSENSUS PROTOCOL FOR EMBRYONAL TUMOR WITH MULTILAYER ROSETTES', Neuro-Oncology, 22, pp. iii324 - iii324, http://dx.doi.org/10.1093/neuonc/noaa222.212

Hamasaki T; Laprise S; Harris PG; Bureau NJ; Gaudreault N; Ziegler D; Choinière M, 2020, 'Efficacy of Nonsurgical Interventions for Trapeziometacarpal (Thumb Base) Osteoarthritis: A Systematic Review', Arthritis Care and Research, 72, pp. 1719 - 1735, http://dx.doi.org/10.1002/acr.24084

Monnerie S; Comte B; Ziegler D; Morais JA; Pujos-Guillot E; Gaudreau P, 2020, 'Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-019-56909-7

Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG; Wong-Erasmus M, 2020, 'Recurrent SPECC1L–NTRK fusions in pediatric sarcoma and brain tumors', Cold Spring Harbor Molecular Case Studies, 6, pp. mcs.a005710, http://dx.doi.org/10.1101/MCS.A005710

Perreault S; Doz F; Drilon A; Geoerger B; Boni V; Chisholm J; Dubois SG; Grilley-Olson JE; Hong DS; Italiano A; Kang H; Nysom K; Øra I; Owens C; Schulte JH; Tahara M; Ziegler D; Ellezam B; Reeves JA; Fellous M; De La Cuesta E; Laetsch TW; van Tilburg CM, 2020, 'CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET', Neuro-Oncology, 22, pp. ii58 - ii58, http://dx.doi.org/10.1093/neuonc/noaa215.233

Dodgshun AJ; Fukuoka K; Edwards M; Bianchi VJ; Das A; Sexton-Oates A; Larouche V; Vanan MI; Lindhorst S; Yalon M; Mason G; Crooks B; Constantini S; Massimino M; Chiaravalli S; Ramdas J; Mason W; Ashraf S; Farah R; Van Damme A; Opocher E; Hamid SA; Ziegler DS; Samuel D; Cole KA; Tomboc P; Stearns D; Thomas GA; Lossos A; Sullivan M; Hansford JR; Mackay A; Jones C; Jones DTW; Ramaswamy V; Hawkins C; Bouffet E; Tabori U, 2020, 'Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns', Acta Neuropathologica, 140, pp. 765 - 776, http://dx.doi.org/10.1007/s00401-020-02209-8

Leach JL; Roebker J; Schafer A; Baugh J; Chaney B; Fuller C; Fouladi M; Lane A; Doughman R; Drissi R; DeWire-Schottmiller M; Ziegler DS; Minturn JE; Hansford JR; Wang SS; Monje-Deisseroth M; Fisher PG; Gottardo NG; Dholaria H; Packer R; Warren K; Leary SES; Goldman S; Bartels U; Hawkins C; Jones BV, 2020, 'MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: Report from the International DIPG Registry', Neuro-Oncology, 22, pp. 1647 - 1657, http://dx.doi.org/10.1093/neuonc/noaa140

Dahine J; Hébert PC; Ziegler D; Chenail N; Ferrari N; Hébert R, 2020, 'Practices in Triage and Transfer of Critically Ill Patients: A Qualitative Systematic Review of Selection Criteria', Critical Care Medicine, 48, pp. E1147 - E1157, http://dx.doi.org/10.1097/CCM.0000000000004624

Wong M; Mayoh C; Lau LMS; Khuong-Quang DA; Pinese M; Kumar A; Barahona P; Wilkie EE; Sullivan P; Bowen-James R; Syed M; Martincorena I; Abascal F; Sherstyuk A; Bolanos NA; Baber J; Priestley P; Dolman MEM; Fleuren EDG; Gauthier ME; Mould EVA; Gayevskiy V; Gifford AJ; Grebert-Wade D; Strong PA; Manouvrier E; Warby M; Thomas DM; Kirk J; Tucker K; O’Brien T; Alvaro F; McCowage GB; Dalla-Pozza L; Gottardo NG; Tapp H; Wood P; Khaw SL; Hansford JR; Moore AS; Norris MD; Trahair TN; Lock RB; Tyrrell V; Haber M; Marshall GM; Ziegler DS; Ekert PG; Cowley MJ; O'Brien T; Wong-Erasmus M, 2020, 'Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer', Nature Medicine, 26, pp. 1742 - 1753, http://dx.doi.org/10.1038/s41591-020-1072-4

Terry RL; Meyran D; Ziegler DS; Haber M; Ekert PG; Trapani JA; Neeson PJ, 2020, 'Immune profiling of pediatric solid tumors', Journal of Clinical Investigation, 130, pp. 3391 - 3402, http://dx.doi.org/10.1172/JCI137181

Clarke M; Mackay A; Ismer B; Pickles JC; Tatevossian RG; Newman S; Bale TA; Stoler I; Izquierdo E; Temelso S; Carvalho DM; Molinari V; Burford A; Howell L; Virasami A; Fairchild AR; Avery A; Chalker J; Kristiansen M; Haupfear K; Dalton JD; Orisme W; Wen J; Hubank M; Kurian KM; Rowe C; Maybury M; Crosier S; Knipstein J; Schüller U; Kordes U; Kram DE; Snuderl M; Bridges L; Martin AJ; Doey LJ; Al-Sarraj S; Chandler C; Zebian B; Cairns C; Natrajan R; Boult JKR; Robinson SP; Sill M; Dunkel IJ; Gilheeney SW; Rosenblum MK; Hughes D; Proszek PZ; Macdonald TJ; Preusser M; Haberler C; Slavc I; Packer R; Ng HK; Caspi S; Popović M; Kotnik BF; Wood MD; Baird L; Davare MA; Solomon DA; Olsen TK; Brandal P; Farrell M; Cryan JB; Capra M; Karremann M; Schittenhelm J; Schuhmann MU; Ebinger M; Dinjens WNM; Kerl K; Hettmer S; Pietsch T; Andreiuolo F; Driever PH; Korshunov A; Hiddingh L; Worst BC; Sturm D; Zuckermann M; Witt O; Bloom T; Mitchell C; Miele E; Colafati GS; Diomedi-Camassei F; Bailey S; Moore AS; Hassall TEG; Lowis SP; Tsoli M; Cowley MJ; Ziegler DS; Karajannis MA; Aquilina K; Hargrave DR; Carceller F; Marshall LV, 2020, 'Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes', Cancer Discovery, 10, pp. 942 - 963, http://dx.doi.org/10.1158/2159-8290.CD-19-1030

Schulte JH; Moreno L; Ziegler DS; Marshall LV; Zwaan CM; Irwin M; Casanova M; Sabado C; Wulff B; Stegert M; Wang L; Hurtado FK; Branle F; Fischer M; Geoerger B, 2020, 'Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK).', Journal of Clinical Oncology, 38, pp. 10505 - 10505, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.10505

Back to profile page